These Are the Only 6 Stock Stocks in NVIDIA's 13F Portfolio

Core Investment Insights - NVIDIA's largest 13F holding is CoreWeave, accounting for 78% of its total reported 13F holdings in Q1, with NVIDIA owning approximately 7% of CoreWeave [4][5] - CoreWeave has seen a 169% increase in stock price since going public in March, largely due to its relationship with NVIDIA [5] Other Significant Holdings - The next largest holdings are Arm and Applied Digital, representing around 10% and 4% of NVIDIA's total $1.15 billion 13F portfolio respectively [6] - NVIDIA attempted to acquire Arm for $40 billion in 2020, but the deal fell through due to regulatory issues [6] - Applied Digital, which rents out computing power, has seen its stock decline approximately 1% since NVIDIA first reported owning it [8][9] AI and Drug Research Investments - Recursion Pharmaceuticals is NVIDIA's fourth largest holding, focusing on AI to accelerate drug discovery, but has not yet generated significant revenue [11] - Recursion's stock is down 51% since NVIDIA's initial investment announcement, despite a 24% jump on the day of the announcement [12] Emerging Companies in AI Computing - Nebius Group and WeRide each make up around 2% of NVIDIA's portfolio, with Nebius reporting a 385% increase in sales in Q1 [13][14] - WeRide operates autonomous driving platforms in China, utilizing NVIDIA's advanced chips [14] Investment Strategy and Market Perception - All companies in NVIDIA's 13F holdings are either customers or suppliers, indicating NVIDIA's deep understanding of their businesses [16] - While NVIDIA's investment is seen as a positive signal, it does not guarantee success for these stocks, as their prices can be volatile [16][17]